SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-049722
Filing Date
2020-04-22
Accepted
2020-04-22 16:16:04
Documents
1
Period of Report
2020-04-16

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1425
  Complete submission text file 0001104659-20-049722.txt   3039
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Trovagene, Inc. (Issuer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O TESARO, INC. 1000 WINTER ST., SUITE 3300 WALTHAM MA 02451
Business Address
Armitage James O (Reporting) CIK: 0001370087 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35558 | Film No.: 20808109